- Report
- March 2024
- 184 Pages
Global
From €3237EUR$3,374USD£2,799GBP
€3597EUR$3,749USD£3,111GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1199EUR$1,250USD£1,037GBP
- Report
- November 2023
- 250 Pages
Global
From €2351EUR$2,450USD£2,033GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4749EUR$4,950USD£4,107GBP
- Report
- April 2023
- 120 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- April 2023
- 161 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- April 2023
- 80 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 60 Pages
Global
From €3790EUR$3,950USD£3,277GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Clinical Trials
- February 2020
- 106 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Report
- January 2022
- 200 Pages
Global
From €7196EUR$7,500USD£6,223GBP
- Report
- March 2020
- 100 Pages
Global
From €4601EUR$4,795USD£3,978GBP
- Report
- December 2022
- 67 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Drug Pipelines
- June 2020
- 82 Pages
Global
From €1919EUR$2,000USD£1,659GBP
Thyroid Eye Disease (TED) is a rare autoimmune disorder that affects the eyes and surrounding tissues. It is caused by an overactive thyroid gland, which produces antibodies that attack the muscles and fatty tissues around the eyes. Symptoms of TED include bulging eyes, double vision, and dry eyes. Treatment for TED typically involves a combination of medications, surgery, and lifestyle changes. Medications used to treat TED include corticosteroids, immunosuppressants, and antithyroid drugs. Surgery may be used to correct double vision, reduce the bulging of the eyes, and improve the appearance of the eyes. Lifestyle changes such as avoiding smoking, reducing stress, and eating a healthy diet can also help manage the symptoms of TED.
Companies in the Thyroid Eye Disease Treatment market include Allergan, Novartis, Pfizer, and Regeneron. Show Less Read more